Lean-mass protection while cutting
One of 6 mechanistic pathways to 🔥 Lose fat · 14 options
Fat loss that takes muscle with it lowers your metabolic rate and guarantees the regain. Any aggressive deficit — and every GLP-1 — needs an answer to this, and it belongs in the fat-loss plan rather than as an afterthought once the scale has moved.
Muscle loss on an aggressive deficit is invisible on the scale and obvious in IGF-1 and testosterone, both of which fall in a sustained deficit. Worth a baseline before you start and a recheck at eight weeks — this is the panel built specifically for people running a GLP-1.
IGF-1 (Insulin-like Growth Factor 1)Total TestosteroneFree TestosteroneComprehensive Metabolic Panel (CMP)💉 On a GLP-1 (Semaglutide / Tirzepatide) covers these in one panel →
What engages this pathway
Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.
💉 Tesamorelin
A GHRH analog with actual trial evidence for reducing visceral adipose tissue specifically, while raising IGF-1 enough to defend lean mass. The most target-specific fat compound in the Vault.
💉 CJC-1295 No Dac
Pulsatile GH release preserves the physiological rhythm. GH is lipolytic and anti-catabolic; the prediction in a deficit is retained lean tissue and better recovery.
💉 Ipamorelin
A selective GH secretagogue with minimal cortisol or prolactin spill. The low-side-effect argument is why it's the default partner for a cutting stack.
💉 CJC No Dac/Ipamorelin
GHRH plus ghrelin-mimetic together produce a larger GH pulse than either alone — genuine synergy rather than additive dosing.
💉 Sermorelin
The gentlest GHRH analog, closest to physiological signaling. Weakest effect, best safety argument.
💉 Bimagrumab
An activin type-II receptor antibody. In human trials it produced the cleanest body-recomposition signal on record — substantial fat loss with lean-mass GAIN — and it is now being trialed specifically as a GLP-1 partner to fix their muscle-loss problem.
💉 Follistatin 344
Binds and neutralizes myostatin. Mechanistically the muscle-preservation argument in a deficit is strong; human data is basically absent and the delivery problem is unsolved.
💉 Follistatin (FLGR242)
FLGR242, sold as a follistatin fragment engineered not to bind activin — the intent being myostatin blockade without the vascular and bleeding problems that stopped the earlier activin-pathway programs. In a deficit the prediction is lean-mass sparing rather than growth. No human trial has tested either half of that.
💉 ACE-083
A locally-acting follistatin-based myostatin trap designed for injection into a specific muscle. Produced local hypertrophy in humans but failed to improve function in its trials.
🧬 Whey Protein (RecoveryPro)
Leucine content and absorption kinetics make it the most reliable acute stimulus for muscle protein synthesis available. Adequate protein is the single largest lever in this pathway and it is not a peptide.
🧬 Essential Amino Acids
Supplies the nine amino acids that must come from diet. Useful when total protein intake is genuinely restricted.
🧬 HMB
A leucine metabolite that reduces proteolysis. The evidence is best in catabolic states — aggressive deficits, illness, detraining — and weak in well-fed trained lifters.
🧬 Creatine
The most evidence-backed supplement in existence. Preserves strength and cell volume through a deficit; ATP resynthesis is unaffected by dieting.
🧬 L-Glutamine
Conditionally essential under metabolic stress. The anti-catabolic case is better in clinical illness than in dieting athletes.
What actually decides this outcome, in order of size
Everything on this page is judged against a body composition number, and that number has a published error bar that most readers have never seen. Ranked by how much of the outcome each one owns:
- Whether the muscle is being given a reason to stay, which is a training variable and not a purchase. Mechanical loading is the signal that tells a fiber to maintain its protein content. Nothing on this shelf substitutes for it, and every compound below is being asked to defend tissue that is not being asked to do anything.
- The precision error of the measurement, which is frequently larger than the change being looked for. Short-term precision error of body composition assessment methods has been quantified in resistance-trained male athletes Farley 2021, and precision, least significant change and validity have been compared across bioelectrical impedance, 3D optical scanning and dual X-ray absorptiometry Oliver 2026. Least significant change is the number that matters: below it, a difference between two scans is the machine talking.
- Whether the change is in tissue or in water and glycogen. Lean soft tissue on a scan includes intracellular water, and glycogen is stored with water bound to it. A reduced carbohydrate intake shrinks that pool within days, and a scan taken across that transition reports a lean mass loss that is a hydration change. This is the single most common false alarm on this page.
- Protein intake, which has a meta-regression rather than an opinion. Protein supplementation and resistance training have been examined in a systematic review with meta-analysis and meta-regression, and the regression identifies a point beyond which additional intake added nothing further to the measured outcome Morton 2018. That is a description of what the pooled trials found. It is not a prescription, and this page does not give one.
- The compounds, last, and the cleanest human recomposition signal is a monoclonal antibody in a trial setting. Bimagrumab against placebo changed body fat mass in adults with type 2 diabetes and obesity in a phase 2 randomized trial Heymsfield 2021, and a later phase 2 study examined it alongside semaglutide Heymsfield 2026. Neither is a product a reader can buy, and both are the reference the rest of this shelf should be judged against.
The order to run these in, and what has to be true first
Establish a measurement you can trust, load the tissue, and take one set of endocrine markers so that the state you are in is a laboratory finding rather than a guess. Every step here is about being able to tell what happened.
- One baseline scan on one device, with that device's own precision error written down. Same machine, same technician, same time of day, same hydration state. The least significant change for that setup is what makes a follow-up interpretable Oliver 2026, and without it a 12-week comparison is two numbers and a hope Farley 2021.
- IGF-1 (Insulin-like Growth Factor 1) with Free T3 (Triiodothyronine) and TSH (Thyroid-Stimulating Hormone) at baseline. These three are the endocrine read-out of energy availability, and they move before anything on a scan does. Insulin-like growth factor 1 falls with reduced energy availability, and free triiodothyronine falls while TSH stays in range, which is the pattern that distinguishes a physiological adaptation from thyroid disease.
- The gonadal axis, on the same draw. Total Testosterone with LH & FSH and SHBG (Sex Hormone-Binding Globulin) for men; Estradiol, Sensitive (LC/MS-MS) with Progesterone and cycle history for women. Loss of gonadotropin pulsatility is one of the earliest measurable consequences of a sustained energy deficit, and the effects of weight loss on fat-free mass, muscle, bone and hematopoiesis have been reviewed together for exactly this reason Stefanakis 2024.
- Creatine first among the purchasables, because it is the best-evidenced supplement in existence and it is unaffected by the state. Loading kinetics were characterized in men decades ago Hultman 1996 and a position stand covers safety and efficacy Kreider 2017. It also raises intracellular water, which is a genuine effect and a confound for the scan.
- Whey Protein (RecoveryPro) and Essential Amino Acids are the substrate tier, and the meta-regression is the reference for what they add Morton 2018. Leucine content and absorption kinetics are what distinguish them from other protein sources acutely. Their role here is convenience and timing rather than a unique property.
- HMB has an umbrella review and it is worth reading before buying. Ergogenic benefits of beta-hydroxy-beta-methylbutyrate on body composition and muscle strength have been assessed in an umbrella review of meta-analyses Bideshki 2025. The effect concentrates in catabolic and untrained states rather than in trained lifters, which makes the population question the first one to ask.
- The growth-hormone axis is next, and the one with real trial evidence has a specific population. Tesamorelin's body composition, hepatic fat, metabolic and safety outcomes have been meta-analyzed in HIV-associated lipodystrophy Badran 2026. That is a well-defined clinical population and the reader of this page is usually not in it. Sermorelin, Ipamorelin, CJC-1295 No Dac and CJC No Dac/Ipamorelin argue from the same axis, and the class review sets out what secretagogues do to body composition and what they cost metabolically Sinha 2020.
- Bimagrumab, Follistatin 344 and ACE-083 are the myostatin and activin tier, and its history is instructive. Antimyostatin treatment in health and disease has been reviewed under the title of great expectations and limited success Nielsen 2021, and a locally-acting follistatin-based trap produced local muscle growth in humans Pearsall 2019. L-Glutamine is last: conditionally essential in clinical catabolic states and much weaker outside them.
What gets bought for this that cannot move it
The category fails on resolution before it fails on pharmacology. A 12-week intervention on this page is looking for a change in lean soft tissue that is frequently smaller than the least significant change of the device measuring it Oliver 2026 Farley 2021. That does not mean nothing happened. It means the instrument cannot say, and a reader who declares success or failure from two scans has read noise as signal in whichever direction they expected.
Muscle that gets bigger is not automatically muscle that does more. A locally-acting myostatin trap produced local hypertrophy in humans and did not deliver the functional improvement its trials were looking for Pearsall 2019, and the wider antimyostatin story has been written up as expectations exceeding results Nielsen 2021. Cross-sectional area and force are different endpoints, and this shelf is sold on the first.
L-Glutamine is the item here whose reputation most exceeds its per-goal prediction. Its anti-catabolic case is built in burns, sepsis and post-surgical states where demand genuinely outstrips synthesis. Transplanting that to a healthy trained person is an extrapolation across a completely different metabolic context, and it is not supported by the trials that produced the original result.
And there is a point at which this page stops. If IGF-1 (Insulin-like Growth Factor 1) and Free T3 (Triiodothyronine) are falling together with a normal TSH (Thyroid-Stimulating Hormone), and LH & FSH or the cycle has gone quiet, that is a measurable endocrine state with consequences for bone and hematopoiesis Stefanakis 2024, and it belongs with a clinician rather than with a shelf. This site does not give eating instructions and this page will not give one. Readers whose goal is appetite belong at Appetite & satiety signaling; readers whose problem is insulin belong at Substrate partitioning & insulin control; readers who want the tissue to grow rather than to be defended belong at Build muscle & strength.
How you would know it was working, on a real read-out and a real timescale
The prediction is that under a maintained training stimulus, the endocrine markers should stay put while fat mass changes. If IGF-1 (Insulin-like Growth Factor 1) and Free T3 (Triiodothyronine) fall together with a normal TSH (Thyroid-Stimulating Hormone), the state has become an endocrine one and no compound on this page is the answer to it.
- IGF-1 (Insulin-like Growth Factor 1) at baseline, 6 weeks and 12 weeks. It is the earliest of these markers to move because hepatic IGF-1 production is sensitive to energy availability, and because its long circulating half-life makes a single draw representative rather than a snapshot of a pulse.
- Free T3 (Triiodothyronine) with TSH (Thyroid-Stimulating Hormone) on the same draws, read as a pair. A falling free triiodothyronine with a normal thyrotropin is the signature of reduced peripheral conversion under low energy availability, and it is not thyroid disease. Reading it as thyroid disease is how people end up on a hormone they do not need; Reverse T3 is the confirmatory analyte if the pattern needs characterizing.
- Total Testosterone with LH & FSH, or Estradiol, Sensitive (LC/MS-MS) with Progesterone and cycle status, at baseline and 12 weeks. This is the axis that reports the same state from the reproductive end, and its suppression is one of the earliest and most reversible findings Stefanakis 2024.
- Complete Blood Count (CBC) with Differential with Ferritin at baseline and 12 weeks. Hematopoiesis is one of the systems the review names as affected Stefanakis 2024, and a falling hemoglobin or ferritin across a 12-week block is a finding rather than an inconvenience.
- The same scan on the same device at 12 and 24 weeks, read against its own least significant change. Twenty-four weeks because the change being looked for is close to the resolution limit at 12 Oliver 2026, and same-device because between-device differences exceed within-device error by a wide margin Farley 2021.
What will fool you. Glycogen carries water, so a scan taken after a low-carbohydrate stretch shows a lean mass loss that returns within days of the carbohydrate returning. Creatine raises intracellular water and therefore raises measured lean mass without any protein being added Kreider 2017. Bioelectrical impedance is more sensitive to hydration than dual X-ray absorptiometry and has a larger least significant change Oliver 2026, so a home scale is not a smaller version of a clinic scan. And a trial result obtained in HIV lipodystrophy Badran 2026 or in adults with type 2 diabetes and obesity Heymsfield 2021 is a result in that population, not a prediction for a trained reader in a deficit.
Sources read for these sections
- Farley A. Short-Term Precision Error of Body Composition Assessment Methods in Resistance-Trained Male Athletes. International Journal of Sport Nutrition and Exercise Metabolism 2021;31(1):55-65 · PMID 33186896
- Oliver CJ. Precision, least significant change and validity of body composition estimates from bioelectrical impedance analysis, 3D-optical scanning, and dual X-ray absorptiometry. Clinical Nutrition ESPEN 2026 · PMID 41662990
- Morton RW. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British Journal of Sports Medicine 2018;52(6):376-384 · PMID 28698222
- Bideshki MV. Ergogenic Benefits of beta-Hydroxy-beta-Methyl Butyrate (HMB) Supplementation on Body Composition and Muscle Strength: An Umbrella Review of Meta-Analyses. Journal of Cachexia Sarcopenia and Muscle 2025;16(1):e13707 · PMID 39797501
- Badran AS. Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials. Obesity Research and Clinical Practice 2026 · PMID 41545261
- Heymsfield SB, et al. Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial. JAMA Network Open 2021 · PMID 33439265
- Heymsfield SB, et al. Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial. Nature Medicine 2026 · PMID 41772149
- Stefanakis K, et al. The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation. Metabolism 2024 · PMID 39481534
- Kreider RB, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition, 2017 · PMID 28615996
- Hultman E, et al. Muscle creatine loading in men. Journal of Applied Physiology, 1996 · PMID 8828669
- Pearsall RS, Davies MV, Cannell M, Li J, Widrick J, Mulivor AW, Wallner S, Troy ME, Spaits M, Liharska K, et al. Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease. Scientific Reports 2019 · PMID 31388039
- Nielsen TL, et al. Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited Success. Cells 2021 · PMID 33802348
- Sinha DK. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology 2020;9(Suppl 2):S149-S159 · PMID 32257855
The other 5 routes to lose fat
Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.
You know the goal. Skool has the plan.
This pathway is one arm of The Lose fat Blueprint. The members' version has where this arm sits in the sequence, what to stack it with, and the markers that tell you to keep going or stop.
Open The Lose fat Blueprint in Skool →$10/mo, cancel anytime.
← Open this pathway in the interactive Vault
Frequently asked questions
Fat loss that takes muscle with it lowers your metabolic rate and guarantees the regain. Any aggressive deficit — and every GLP-1 — needs an answer to this, and it belongs in the fat-loss plan rather than as an afterthought once the scale has moved.
14 options are mapped to this pathway in the Vault, including Tesamorelin, CJC-1295 No Dac, Ipamorelin, CJC No Dac/Ipamorelin. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 7 carry clinical validation and 7 are mechanistic predictions.
Muscle loss on an aggressive deficit is invisible on the scale and obvious in IGF-1 and testosterone, both of which fall in a sustained deficit. Worth a baseline before you start and a recheck at eight weeks — this is the panel built specifically for people running a GLP-1. The markers worth checking are IGF-1 (Insulin-like Growth Factor 1), Total Testosterone, Free Testosterone, Comprehensive Metabolic Panel (CMP).
Unproven is not the same as ineffective. Of the 14 options on this pathway, 7 have clinical validation and 7 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.
Where this goes next
Everything above is the free case for Lean-mass protection while cutting. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.